Emmi Valuation
Is 0QM5 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0QM5 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0QM5 (CHF834) is trading below our estimate of fair value (CHF2388.38)
Significantly Below Fair Value: 0QM5 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0QM5?
Other financial metrics that can be useful for relative valuation.
What is 0QM5's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 4.50b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.2x |
Enterprise Value/EBITDA | 13.2x |
PEG Ratio | 1.8x |
Price to Earnings Ratio vs Peers
How does 0QM5's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 17.3x | ||
CWK Cranswick | 24.6x | 7.8% | UK£2.8b |
TATE Tate & Lyle | 16x | 11.6% | UK£2.9b |
PFD Premier Foods | 14.6x | 4.5% | UK£1.6b |
BAKK Bakkavor Group | 14x | 11.2% | UK£896.4m |
0QM5 Emmi | 23.1x | 13.0% | CHF 4.4b |
Price-To-Earnings vs Peers: 0QM5 is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the peer average (17.3x).
Price to Earnings Ratio vs Industry
How does 0QM5's PE Ratio compare vs other companies in the European Food Industry?
Price-To-Earnings vs Industry: 0QM5 is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the European Food industry average (14x).
Price to Earnings Ratio vs Fair Ratio
What is 0QM5's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 23.3x |
Fair PE Ratio | 18.8x |
Price-To-Earnings vs Fair Ratio: 0QM5 is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the estimated Fair Price-To-Earnings Ratio (18.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 846.00 | CHF 1,000.25 +18.2% | 10.3% | CHF 1,100.00 | CHF 855.00 | n/a | 4 |
Oct ’25 | CHF 856.00 | CHF 1,000.25 +16.9% | 10.3% | CHF 1,100.00 | CHF 855.00 | n/a | 4 |
Sep ’25 | CHF 883.00 | CHF 1,000.25 +13.3% | 10.3% | CHF 1,100.00 | CHF 855.00 | n/a | 4 |
Aug ’25 | CHF 924.00 | CHF 998.25 +8.0% | 10.2% | CHF 1,100.00 | CHF 855.00 | n/a | 4 |
Jul ’25 | CHF 893.00 | CHF 993.60 +11.3% | 9.4% | CHF 1,100.00 | CHF 840.00 | n/a | 5 |
Jun ’25 | CHF 900.00 | CHF 990.80 +10.1% | 9.2% | CHF 1,100.00 | CHF 840.00 | n/a | 5 |
May ’25 | CHF 895.52 | CHF 990.80 +10.6% | 9.2% | CHF 1,100.00 | CHF 840.00 | n/a | 5 |
Apr ’25 | CHF 897.46 | CHF 989.00 +10.2% | 9.1% | CHF 1,100.00 | CHF 840.00 | n/a | 5 |
Mar ’25 | CHF 908.15 | CHF 993.00 +9.3% | 9.2% | CHF 1,100.00 | CHF 840.00 | n/a | 5 |
Feb ’25 | CHF 904.00 | CHF 998.20 +10.4% | 9.7% | CHF 1,100.00 | CHF 815.00 | n/a | 5 |
Jan ’25 | CHF 910.05 | CHF 1,009.40 +10.9% | 10.8% | CHF 1,150.00 | CHF 815.00 | n/a | 5 |
Dec ’24 | CHF 900.13 | CHF 1,009.40 +12.1% | 10.8% | CHF 1,150.00 | CHF 815.00 | n/a | 5 |
Nov ’24 | CHF 859.91 | CHF 1,009.40 +17.4% | 10.8% | CHF 1,150.00 | CHF 815.00 | n/a | 5 |
Oct ’24 | CHF 864.00 | CHF 1,009.40 +16.8% | 10.8% | CHF 1,150.00 | CHF 815.00 | CHF 856.00 | 5 |
Sep ’24 | CHF 930.49 | CHF 982.00 +5.5% | 11.9% | CHF 1,150.00 | CHF 815.00 | CHF 883.00 | 6 |
Aug ’24 | CHF 853.91 | CHF 969.60 +13.5% | 7.5% | CHF 1,071.00 | CHF 847.00 | CHF 924.00 | 5 |
Jul ’24 | CHF 858.28 | CHF 964.60 +12.4% | 6.9% | CHF 1,046.00 | CHF 847.00 | CHF 893.00 | 5 |
Jun ’24 | CHF 926.09 | CHF 964.60 +4.2% | 6.9% | CHF 1,046.00 | CHF 847.00 | CHF 900.00 | 5 |
May ’24 | CHF 929.54 | CHF 964.60 +3.8% | 6.9% | CHF 1,046.00 | CHF 847.00 | CHF 895.52 | 5 |
Apr ’24 | CHF 917.91 | CHF 932.17 +1.6% | 10.2% | CHF 1,046.00 | CHF 770.00 | CHF 897.46 | 6 |
Mar ’24 | CHF 869.12 | CHF 944.00 +8.6% | 11.3% | CHF 1,100.00 | CHF 770.00 | CHF 908.15 | 6 |
Feb ’24 | CHF 866.41 | CHF 942.67 +8.8% | 11.1% | CHF 1,100.00 | CHF 770.00 | CHF 904.00 | 6 |
Jan ’24 | CHF 783.08 | CHF 910.20 +16.2% | 8.6% | CHF 1,013.00 | CHF 770.00 | CHF 910.05 | 5 |
Dec ’23 | CHF 828.10 | CHF 920.20 +11.1% | 6.6% | CHF 1,013.00 | CHF 820.00 | CHF 900.13 | 5 |
Nov ’23 | CHF 798.49 | CHF 916.20 +14.7% | 6.7% | CHF 1,013.00 | CHF 820.00 | CHF 859.91 | 5 |
Oct ’23 | CHF 769.00 | CHF 916.20 +19.1% | 6.7% | CHF 1,013.00 | CHF 820.00 | CHF 864.00 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.